<code id='9396335788'></code><style id='9396335788'></style>
    • <acronym id='9396335788'></acronym>
      <center id='9396335788'><center id='9396335788'><tfoot id='9396335788'></tfoot></center><abbr id='9396335788'><dir id='9396335788'><tfoot id='9396335788'></tfoot><noframes id='9396335788'>

    • <optgroup id='9396335788'><strike id='9396335788'><sup id='9396335788'></sup></strike><code id='9396335788'></code></optgroup>
        1. <b id='9396335788'><label id='9396335788'><select id='9396335788'><dt id='9396335788'><span id='9396335788'></span></dt></select></label></b><u id='9396335788'></u>
          <i id='9396335788'><strike id='9396335788'><tt id='9396335788'><pre id='9396335788'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:967
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Black vets could get higher VA benefits if race not used in lung test
          Black vets could get higher VA benefits if race not used in lung test

          AdobeRemovingapatient’sracefromanequationusedtoassesslungfunction—achangecalledforbyhealthequityadvo

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha